| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Internal Medicine (Section 4), Sapporo Medical College, South-1, West-16, Chyo-ku, Sapporo, 060, Japan
Based on the finding that expression of endogenous tumor necrosis factor (TNF) which is not detected in TNF-susceptible cells was observed in TNF-resistant cells, the assumption was made that endogenous TNF may be a protective protein against the cytotoxic activity of TNF. In order to confirm this possibility, we investigated the relationship between expression of endogenous TNF and TNF susceptibility by using the gene transfection method.
When L-M, TNF-highly sensitive murine fibrosarcoma cells were transfected with a human TNF gene, the stable transfectants expressed endogenous TNF and acquired resistance to TNF. Conversely, when endogenous TNF synthesis was inhibited by introducing an antisense TNF gene into HeLa, TNF-less sensitive human cervical cancer cells, the sensitivity was enhanced.
These findings indicate that endogenous TNF is one of the protective factors against the cytotoxic activity of TNF.
1 To whom requests for reprints should be addressed.
Received 1/19/90.
Revised 4/20/90.
This article has been cited by other articles:
|
|
 |
|
  W. Reiley, M. Zhang, and S.-C. Sun Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD J. Biol. Chem., December 31, 2004; 279(53): 55161 - 55167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Wu, C. N. Pabin, Z. Qin, T. Blankenstein, M. Philip, J. Dignam, K. Schreiber, and H. Schreiber Long-Term Suppression of Tumor Growth by TNF Requires a Stat1- and IFN Regulatory Factor 1-Dependent IFN-{gamma} Pathway but Not IL-12 or IL-18 J. Immunol., March 1, 2004; 172(5): 3243 - 3251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chovolou, W. Watjen, A. Kampkotter, and R. Kahl Resistance to Tumor Necrosis Factor-{alpha} (TNF-{alpha})-induced Apoptosis in Rat Hepatoma Cells Expressing TNF-{alpha} Is Linked to Low Antioxidant Enzyme Expression J. Biol. Chem., August 8, 2003; 278(32): 29626 - 29632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Jones, E. C. Ledgerwood, J. B. Prins, J. Galbraith, D. R. Johnson, J. S. Pober, and J. R. Bradley TNF Recruits TRADD to the Plasma Membrane But Not the trans-Golgi Network, the Principal Subcellular Location of TNF-R1 J. Immunol., January 15, 1999; 162(2): 1042 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Giri and B. B. Aggarwal Constitutive Activation of NF-kappa B Causes Resistance to Apoptosis in Human Cutaneous T Cell Lymphoma HuT-78 Cells. AUTOCRINE ROLE OF TUMOR NECROSIS FACTOR AND REACTIVE OXYGEN INTERMEDIATES J. Biol. Chem., May 29, 1998; 273(22): 14008 - 14014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Decoster, B. Vanhaesebroeck, E. Boone, S. Plaisance, K. De Vos, G. Haegeman, J. Grooten, and W. Fiers Induction of Unresponsiveness to Tumor Necrosis Factor (TNF) after Autocrine TNF Expression Requires TNF Membrane Retention J. Biol. Chem., February 6, 1998; 273(6): 3271 - 3277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kobayashi, N. Watanabe, N. Yamauchi, N. Tsuji, T. Sato, and Y. Niitsu Endogenous Tumor Necrosis Factor as a Predictor of Doxorubicin Sensitivity in Leukemic Patients Blood, April 1, 1997; 89(7): 2472 - 2479. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
